Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Earnings	Accelerate Diagnostics reports Q1 EPS (17c) vs. (20c) last year » 16:17 05/11/23 05/11 16:17 05/11/23 16:17 AXDX Accelerate Diagnostics / + Reports Q1 revenue $2.8M… Reports Q1 revenue $2.8M vs. $3M last year. ShowHide Related Items >><< Company News Earnings Syndicate On The Fly Events AXDX Accelerate Diagnostics / + 03/14/23 Accelerate Diagnostics CFO Steve Reichling to step down 12/19/22 Accelerate Diagnostics submits 510(k) application to FDA for PhenoTest BC Kit AXDX Accelerate Diagnostics / + 03/29/23 Accelerate Diagnostics reports Q4 EPS (15c), consensus (15c) 11/14/22 Accelerate Diagnostics reports Q3 EPS (18c), consensus (19c) 19 Aug AXDX Accelerate Diagnostics / + 11/14/22 Fly Intel: After-Hours Movers 05/11/23 Accelerate Diagnostics - AXDX 05/19/23 Accelerate Diagnostics, Inc.

Over a month ago
Earnings	Accelerate Diagnostics reports Q4 EPS (15c), consensus (15c) » 16:07 03/29/23 03/29 16:07 03/29/23 16:07 AXDX Accelerate Diagnostics / + Reports Q4 revenue $3.0M,… Reports Q4 revenue $3.0M, consensus $2.87M. "In 2022, we achieved another year of revenue growth thanks to our base book of satisfied customers," commented Jack Phillips, CEO. "Though we fell short of our guidance target, we're emboldened by our new partnership with Becton Dickinson and the significant product development milestones we've achieved. The Accelerate Team is fully committed to driving growth and delivering value to our stakeholders." ShowHide Related Items >><< Company News Earnings Syndicate On The Fly Events AXDX Accelerate Diagnostics / + 03/14/23 Accelerate Diagnostics CFO Steve Reichling to step down 12/19/22 Accelerate Diagnostics submits 510(k) application to FDA for PhenoTest BC Kit 10/21/22 Accelerate Diagnostics in talks with FDA regarding Accelerate Arc system AXDX Accelerate Diagnostics / + 11/14/22 Accelerate Diagnostics reports Q3 EPS (18c), consensus (19c) 19 Aug AXDX Accelerate Diagnostics / + 11/14/22 Fly Intel: After-Hours Movers 03/29/23 Accelerate Diagnostics - AXDX
Hot Stocks	Accelerate Diagnostics CFO Steve Reichling to step down » 20:12 03/14/23 03/14 20:12 03/14/23 20:12 AXDX Accelerate Diagnostics / + On March 9, 2023, Steve… On March 9, 2023, Steve Reichling "notified Accelerate Diagnostics of his decision to resign as CFO of the Company, effective March 31, 2023. Mr. Reichling currently serves as the Company's principal financial officer and principal accounting officer. Mr. Reichling's resignation is for personal reasons and is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. In connection with Mr. Reichling's resignation, on March 9, 2023, the Company and Mr. Reichling entered into a consulting services agreement, pursuant to which Mr. Reichling has agreed to provide certain consulting and transitional services to the Company beginning April 3, 2023 through December 29, 2023, unless earlier terminated in accordance with the Reichling Consulting Agreement. In consideration of the services to be provided by Mr. Reichling, the Company will grant him 275,248 shares of the Company's common stock on or about April 3, 2023, with 50% of such shares vesting immediately upon grant, 25% vesting on or about August 13, 2023 and the remaining 25% vesting on or about December 13, 2023. Mr. Reichling has also agreed to certain covenants regarding non-solicitation, confidentiality and intellectual property rights." ShowHide Related Items >><< Company News Earnings Syndicate On The Fly Events AXDX Accelerate Diagnostics / + 12/19/22 Accelerate Diagnostics submits 510(k) application to FDA for PhenoTest BC Kit 10/21/22 Accelerate Diagnostics in talks with FDA regarding Accelerate Arc system AXDX Accelerate Diagnostics / + 11/14/22 Accelerate Diagnostics reports Q3 EPS (18c), consensus (19c) 19 Aug AXDX Accelerate Diagnostics / + 11/14/22 Fly Intel: After-Hours Movers 03/29/23 Accelerate Diagnostics - AXDX

Over a quarter ago
Hot Stocks	Accelerate Diagnostics submits 510(k) application to FDA for PhenoTest BC Kit » 13:34 12/19/22 12/19 13:34 12/19/22 13:34 AXDX Accelerate Diagnostics / + Accelerate Diagnostics… Accelerate Diagnostics announced that the Company has submitted a 510(k) application to the FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest BC kit. Included in the submission are additional escalation and de-escalation agents for Gram-negative organisms, additional antibiotics for Acinetobacter baumannii, and breakpoint updates. These updates add oral de-escalation antibiotic options for clinicians to use, which can assist with expediting patient discharge plans. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AXDX Accelerate Diagnostics / + 10/21/22 Accelerate Diagnostics in talks with FDA regarding Accelerate Arc system 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc AXDX Accelerate Diagnostics / + 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum AXDX Accelerate Diagnostics / + 11/14/22 Accelerate Diagnostics reports Q3 EPS (18c), consensus (19c) 19 Aug AXDX Accelerate Diagnostics / + 11/14/22 Fly Intel: After-Hours Movers 08/17/22 Fly Intel: After-Hours Movers
On The Fly	Fly Intel: After-Hours Movers » 19:00 11/14/22 11/14 19:00 11/14/22 19:00 SHLS Shoals Technologies $22.49 / -0.265 (-1.16%) , HLLY Holley $2.98 / -0.215 (-6.74%) , TDUP ThredUP / + , ACLX Arcellx $21.54 / -0.88 (-3.93%) , NRDY Nerdy $2.14 / -0.195 (-8.35%) , FXLV F45 Training $3.21 / -0.26 (-7.49%) , DLO DLocal $22.62 / -0.18 (-0.79%) , TSM TSMC $72.81 / -1.02 (-1.38%) , POWW AMMO $3.16 / +0.05 (+1.61%) , TXMD TherapeuticsMD $6.51 / -0.44 (-6.33%) , GAN Gan Limited $1.70 / +0.02 (+1.19%) , QRHC Quest Resource $8.36 / -0.47 (-5.32%) , DNA Ginkgo Bioworks $2.69 / -0.17 (-5.95%) , NRGV Energy Vault $3.21 / +0.015 (+0.47%) , AXDX Accelerate Diagnostics $1.50 / +0.08 (+5.63%) , BLU Bellus Health $9.07 / -0.22 (-2.37%) , AZTA Azenta $46.60 / -2.41 (-4.92%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TXMD TSM TDUP SHLS QRHC POWW NRGV NRDY HLLY GAN FXLV DNA BLU AZTA AXDX ACLX TXMD TherapeuticsMD $6.51 / -0.44 (-6.33%) 09/12/22 TherapeuticsMD names Dr. Brian Bernick, Mark Glickman as interim co-CEOs 08/15/22 TherapeuticsMD spikes after Q2 results beat consensus 08/01/22 TherapeuticsMD receives $15M equity investment from Rubric Capital 07/13/22 TherapeuticsMD plunges after saying merger deal anticipated to be terminated TSM TSMC $72.81 / -1.02 (-1.38%) 11/14/22 TSMC jumps 7% to $77.91 after Berkshire Hathaway disclosed added stake 11/14/22 Berkshire Hathaway adds TSMC, exits STORE Capital in Q3 10/26/22 Synopsys, TSMC partner over multi-die design solutions 08/30/22 Gogoro partners with TSMC to launch GoShare in Taichung City TDUP ThredUP / + 10/04/22 ThredUP, RealReal up about 7% each in premarket after acquisition of Poshmark 08/11/22 PVH Corp., ThredUP introduce 360-resale program in the U.S. 08/04/22 ThredUP announces Noelle Sadler as CMO 06/23/22 ThredUP to join Russell 3000 Index SHLS Shoals Technologies $22.49 / -0.265 (-1.16%) 11/14/22 Shoals Technologies jumps 16% to $26.10 after Q3 earnings beat 11/02/22 Shoals Technologies to supply 1 GWdc Solar + Storage Project 09/20/22 Shoals Technologies, Nextracker unveil new North-South BLA trunk bus product 08/15/22 Shoals Technologies names Dominic Bardos as CFO QRHC Quest Resource $8.36 / -0.47 (-5.32%) 10/12/22 Quest Resource appoints Brett Johnston as CFO POWW AMMO $3.16 / +0.05 (+1.61%) 11/07/22 AMMO reaches settlement agreement with The Urvan Group 10/26/22 AMMO to export 2.5M rounds of .50BMG 10/20/22 AMMO says new Wisconsin plant offers lab, range facilities 10/17/22 AMMO planned launch of proprietary eCommerce payment NRGV Energy Vault $3.21 / +0.015 (+0.47%) 11/08/22 Energy Vault appoints Jan Kees van Gaalen as CFO 10/26/22 Energy Vault announces Notice of Award from Meadow Creek Solar 09/27/22 Energy Vault rises 8.6% 09/08/22 Energy Vault signs SESS EPS contract with Wellhead Electric and W Power NRDY Nerdy $2.14 / -0.195 (-8.35%) 08/23/22 Nerdy rises 17.3% 08/17/22 Nerdy falls -18.4% 08/15/22 Nerdy acquires Varsity Tutors, terms not stated 06/13/22 Nerdy CEO buys $480K in common stock HLLY Holley $2.98 / -0.215 (-6.74%) 11/14/22 Holley names Brian Appelgate as interim COO 08/01/22 Holley falls -14.0% 07/29/22 Holley falls -35.9% GAN Gan Limited $1.70 / +0.02 (+1.19%) 10/27/22 Nevada reports September statewide gaming win up 7.87% to $1.25B 10/18/22 New Jersey reports September gaming revenue up 6.9% to $485M 09/29/22 Nevada reports August statewide gaming win up 3.53% to $1.21B 09/28/22 Gan Limited launches Gan Sports in Mississippi FXLV F45 Training $3.21 / -0.26 (-7.49%) 10/03/22 F45 Training confirms receipt of unsolicited buyout proposal from Kennedy Lewis 09/30/22 F45 Training rises 40.0% 09/30/22 F45 Training rises 42.9% 09/30/22 F45 Training receives $4 per share takeover offer from Kennedy Lewis DNA Ginkgo Bioworks $2.69 / -0.17 (-5.95%) 11/11/22 Ginkgo Bioworks and Lygos partner to optimize production of biobased chemicals 10/25/22 Ginkgo Bioworks selected by Saudi Arabia for biotechnology initiatives 10/20/22 Ginkgo Bioworks collaborates with Bolt Threads for optimization of Mylo material 10/19/22 Ginkgo Bioworks completes acquisition of Zymergen BLU Bellus Health $9.07 / -0.22 (-2.37%) 07/12/22 Bellus Health announces EOP2 meeting with FDA, details of BLU-5937 trial AZTA Azenta $46.60 / -2.41 (-4.92%) 11/14/22 Azenta jumps 33% to $62.07 after Q4 earnings beat and guidance 11/14/22 Azenta approves $1.5B share repurchase program 11/14/22 Azenta reports nomination of Tina Nova, Dorothy Puhy to board of directors 11/08/22 Azenta and Government of Luxembourg sign MoU AXDX Accelerate Diagnostics $1.50 / +0.08 (+5.63%) 10/21/22 Accelerate Diagnostics in talks with FDA regarding Accelerate Arc system 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc 05/16/22 Accelerate Diagnostics begins commercialization of Accelerate Arc system ACLX Arcellx $21.54 / -0.88 (-3.93%) 06/23/22 Beneficial owner of Arcellx New Enterprise Associates buys $5M in shares 06/21/22 Arcellx names Maryam Abdul-Kareem as General Counsel 06/03/22 Arcellx reports 'positive' clinical data from Phase 1 CART-ddBCMA study 05/23/22 Arcellx appoints Michelle Gilson as CFO SHLS HLLY TDUP ACLX NRDY FXLV DLO TSM POWW TXMD GAN QRHC DNA NRGV AXDX BLU AZTA SHLS Shoals Technologies $22.49 / -0.265 (-1.16%) 11/10/22 Morgan Stanley New California 'NEM 3.0' proposal 'screens positive,' says Morgan Stanley 10/20/22 JPMorgan Shoals Technologies price target lowered to $32 from $35 at JPMorgan 09/16/22 TD Cowen Cowen upgrades Shoals to Outperform, sees 'compelling opportunity' 09/16/22 TD Cowen Shoals Technologies upgraded to Outperform from Market Perform at Cowen HLLY Holley $2.98 / -0.215 (-6.74%) 10/05/22 Truist Holley price target lowered to $8 from $10 at Truist 08/12/22 Truist Holley price target lowered to $10 from $15 at Truist 08/09/22 Imperial Capital Holley initiated with an Outperform at Imperial Capital 07/29/22 Jefferies Holley downgraded to Hold on business deceleration at Jefferies TDUP ThredUP / + 08/15/22 Barclays ThredUP assumed with an Overweight at Barclays 07/22/22 Piper Sandler ThredUP downgraded to Neutral from Overweight at Piper Sandler 07/21/22 KeyBanc KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view 07/20/22 KeyBanc ThredUP initiated with a Sector Weight at KeyBanc ACLX Arcellx $21.54 / -0.88 (-3.93%) 10/31/22 Guggenheim Arcellx initiated with a Buy at Guggenheim 10/27/22 Needham Arcellx initiated with a Buy at Needham 07/20/22 Canaccord Canaccord starts Arcellx at Buy, sees 'best-in-class' potential 07/20/22 Canaccord Arcellx initiated with a Buy at Canaccord NRDY Nerdy $2.14 / -0.195 (-8.35%) 10/18/22 Barclays Nerdy price target lowered to $2.50 from $4 at Barclays 06/29/22 JPMorgan Nerdy price target lowered to $6 from $7 at JPMorgan 05/27/22 Canaccord Nerdy price target lowered to $7 from $8 at Canaccord 05/17/22 JMP Securities Nerdy price target lowered to $7 from $11 at JMP Securities FXLV F45 Training $3.21 / -0.26 (-7.49%) 10/04/22 JPMorgan F45 Training assumed with Neutral from Overweight at JPMorgan 08/16/22 Roth MKM F45 Training reinstated with a Neutral at Roth Capital 07/28/22 Guggenheim F45 Training downgraded to Neutral at Guggenheim on near-term uncertainty 07/28/22 Guggenheim F45 Training downgraded to Neutral from Buy at Guggenheim DLO DLocal $22.62 / -0.18 (-0.79%) 09/26/22 SMBC Nikko dLocal downgraded to Underperform from Neutral at SMBC Nikko 05/19/22 Citi dLocal price target lowered to $26 from $31 at Citi 05/09/22 New Street New Street upgrades dLocal to Buy, sees good entry point 05/09/22 New Street dLocal upgraded to Buy from Neutral at New Street TSM TSMC $72.81 / -1.02 (-1.38%) 10/17/22 Northland Teradyne price target lowered to $74 from $85 at Northland 10/13/22 Goldman Sachs TSMC downgraded to Buy from Conviction Buy at Goldman Sachs 10/10/22 Northland Intel price target lowered to $52 from $55 at Northland 09/14/22 Daiwa TSMC upgraded to Buy from Outperform at Daiwa POWW AMMO $3.16 / +0.05 (+1.61%) 08/16/22 Lake Street AMMO price target lowered to $9 from $12 at Lake Street 06/30/22 EF Hutton AMMO shares should be bought 'aggressively,' says EF Hutton TXMD TherapeuticsMD $6.51 / -0.44 (-6.33%) 07/15/22 H.C. Wainwright H.C. Wainwright suspends rating on TherapeuticsMD with merger terminated 06/07/22 H.C. Wainwright TherapeuticsMD downgraded to Neutral from Buy at H.C. Wainwright 05/06/22 Cantor Fitzgerald TherapeuticsMD downgraded to Neutral from Overweight at Cantor Fitzgerald 05/06/22 Cantor Fitzgerald TherapeuticsMD downgraded to Neutral from Overweight at Cantor Fitzgerald GAN Gan Limited $1.70 / +0.02 (+1.19%) 09/29/22 Northland Gan Limited price target lowered to $2.50 from $3.50 at Northland 06/28/22 B. Riley Gan Limited price target lowered to $6.50 from $10 at B. Riley 03/23/22 Craig-Hallum Gan Limited price target lowered to $8 from $14 at Craig-Hallum 03/23/22 B. Riley Gan Limited price target lowered to $10 from $26 at B. Riley QRHC Quest Resource $8.36 / -0.47 (-5.32%) 04/18/22 EF Hutton Quest Resource initiated with a Buy at EF Hutton 02/14/22 Craig-Hallum Craig-Hallum bullish on Quest Resource, initiates with a Buy 02/14/22 Craig-Hallum Quest Resource initiated with a Buy at Craig-Hallum 12/10/21 H.C. Wainwright Quest Resource price target raised to $12 from $10 at H.C. Wainwright DNA Ginkgo Bioworks $2.69 / -0.17 (-5.95%) 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 08/16/22 Raymond James Ginkgo Bioworks price target raised to $14.50 from $11.50 at Raymond James 07/26/22 William Blair Zymergen buyout deal 'best case scenario,' says William Blair NRGV Energy Vault $3.21 / +0.015 (+0.47%) 10/06/22 Guggenheim Energy Vault price target lowered to $10 from $15 at Guggenheim 08/09/22 TD Cowen Energy Vault price target lowered to $11.50 from $18 at Cowen 06/29/22 Chardan Energy Vault initiated with a Buy at Chardan 03/22/22 Guggenheim Guggenheim starts Energy Vault at Buy, sees plans as 'ambitious but plausible' AXDX Accelerate Diagnostics $1.50 / +0.08 (+5.63%) 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum BLU Bellus Health $9.07 / -0.22 (-2.37%) 09/23/22 Jefferies Bellus Health price target raised to $21 from $14 at Jefferies 08/11/22 H.C. Wainwright Bellus Health price target raised to $20 from $16 at H.C. Wainwright 07/13/22 RBC Capital Bellus Health price target raised to $19 from $14 at RBC Capital 07/12/22 H.C. Wainwright H.C. Wainwright says Bellus set for 'show down' against Merck's gefapixant AZTA Azenta $46.60 / -2.41 (-4.92%) 10/24/22 KeyBanc Azenta price target lowered to $70 from $90 at KeyBanc 10/04/22 Evercore ISI Azenta added to 'TAP Underperform' list at Evercore ISI 07/14/22 B. Riley Azenta price target lowered to $82 from $94 at B. Riley 05/17/22 B. Riley Azenta price target lowered to $94 from $106 at B. Riley TXMD TSM TDUP SHLS QRHC POWW NRGV NRDY HLLY GAN FXLV DNA DLO BLU AZTA AXDX ACLX TXMD TherapeuticsMD $6.51 / -0.44 (-6.33%) 11/14/22 TherapeuticsMD reports Q3 EPS ($3.13) vs. ($5.62) a year ago 05/16/22 TherapeuticsMD reports Q1 EPS ($5.69) vs. ($5.67) last year TSM TSMC $72.81 / -1.02 (-1.38%) 10/13/22 TSMC sees Q4 revenue $19.9B-$20.7B, consensus $19.76B 10/13/22 TSMC reports Q3 EPS $1.79, consensus $1.41 07/14/22 TSMC sees Q3 revenue $19.8B-$20.6B, consensus $19.21B 07/14/22 TSMC reports Q2 EPS $1.55, consensus $1.47 TDUP ThredUP / + 11/14/22 ThredUP sees 2022 revenue $279M-$281M, consensus $285.64M 11/14/22 ThredUP sees Q4 revenue $62M-$64M, consensus $71.17M 11/14/22 ThredUP reports Q3 EPS (24c), consensus (22c) 08/15/22 ThredUP sees Q3 revenue $64M-$66M, consensus $82.43M SHLS Shoals Technologies $22.49 / -0.265 (-1.16%) 11/14/22 Shoals Technologies narrows FY22 revenue view to $310M-$325M from $300M-$325M 11/14/22 Shoals Technologies reports Q3 adjusted EPS 10c, consensus 8c 08/15/22 Shoals Technologies sees FY22 revenue $300M-$325M, consensus $312.58M 08/15/22 Shoals Technologies reports Q2 EPS 4c, consensus 7c QRHC Quest Resource $8.36 / -0.47 (-5.32%) 11/14/22 Quest Resource reports Q3 EPS 4c, consensus (3c) 08/15/22 Quest Resource reports Q2 EPS 19c vs. 5c in 2Q21 05/16/22 Quest Resource reports Q1 adjusted EPS 6c, consensus 3c 05/16/22 Quest Resource reports Q1 EPS 7c, consensus 3c POWW AMMO $3.16 / +0.05 (+1.61%) 11/14/22 AMMO lowers FY23 revenue view to $220M-$240M, consensus $295.12M 11/14/22 AMMO reports Q2 adjusted EPS 5c, consensus 4c 08/15/22 AMMO reports Q1 EPS 9c vs. 13c last year 06/29/22 AMMO sees FY 23 revenue $300M -$310M, consensus $311.77M NRGV Energy Vault $3.21 / +0.015 (+0.47%) 11/14/22 Energy Vault backs FY22 revenue view $75M-$100M, consensus $82.09M 11/14/22 Energy Vault reports Q3 EPS (21c), two estimates (10c) 08/08/22 Energy Vault reports Q2 EPS (5c), consensus (2c) NRDY Nerdy $2.14 / -0.195 (-8.35%) 11/14/22 Nerdy sees FY22 revenue $160M-$162M, consensus $167.8M 11/14/22 Nerdy sees Q4 revenue $39M-$41M, consensus $47.2M 11/14/22 Nerdy reports Q3 EPS (21c), consensus (29c) 08/15/22 Nerdy backs FY22 revenue view $160M-$175M, consensus $167.38M HLLY Holley $2.98 / -0.215 (-6.74%) 11/14/22 Holley sees FY22 revenue $695M-$710M, consensus $706.7M 11/14/22 Holley reports Q3 EPS 27c, consensus 6c 08/11/22 Holley reports Q2 EPS 35c, consensus 26c 07/28/22 Holley lowers FY22 revenue view to $700M- $725M from $765M-$790M GAN Gan Limited $1.70 / +0.02 (+1.19%) 11/14/22 Gan Limited reports Q3 EPS (16c), consensus (17c) 08/15/22 Gan Limited reports Q2 EPS (91c), consensus (13c) 05/16/22 Gan Limited reports Q1 EPS (11c), consensus (10c) FXLV F45 Training $3.21 / -0.26 (-7.49%) 11/14/22 F45 Training sees FY22 revenue $120M-$130M, consensus $130.48M 11/14/22 F45 Training reports Q3 EPS (62c), consensus (2c) 08/15/22 F45 Training sees FY22 revenue $120M-$130M , consensus $225.0M 08/15/22 F45 Training reports Q2 EPS (36c), consensus 14c DNA Ginkgo Bioworks $2.69 / -0.17 (-5.95%) 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M 08/15/22 Ginkgo Bioworks reports Q2 EPS (41c), consensus (4c) DLO DLocal $22.62 / -0.18 (-0.79%) 11/14/22 dLocal reports Q3 EPS 10c, consensus 11c 08/22/22 dLocal reports Q2 EPS 10c, consensus 10c 05/17/22 dLocal reports Q1 EPS 8c, consensus 8c BLU Bellus Health $9.07 / -0.22 (-2.37%) 11/14/22 Bellus Health reports Q3 EPS (20c), consensus (17c) 08/10/22 Bellus Health reports Q2 EPS (18c), consensus (16c) AZTA Azenta $46.60 / -2.41 (-4.92%) 11/14/22 Azenta sees FY23 revenue up 30% from $555.50M in FY22 11/14/22 Azenta sees Q1 non-GAAP EPS 8c-16c, one estimate 9c 11/14/22 Azenta reports Q4 non-GAAP EPS 16c, consensus 6c 08/09/22 Azenta sees Q4 adjusted EPS 4c-12c, consensus 12c AXDX Accelerate Diagnostics $1.50 / +0.08 (+5.63%) 11/14/22 Accelerate Diagnostics reports Q3 EPS (18c), consensus (19c) 05/16/22 Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c) ACLX Arcellx $21.54 / -0.88 (-3.93%) 11/14/22 Arcellx reports Q3 EPS ($2.12), consensus (89c) 08/15/22 Arcellx reports Q2 EPS (88c), consensus ($1.07) 19 Aug 14 Jul 17 Jun 21 Apr 04 Feb 15 Dec TSM SHLS POWW NRGV GAN FXLV TSM TSMC $72.81 / -1.02 (-1.38%) 11/09/22 TSMC considering multibillion-dollar Arizona plant expansion, WSJ reports 11/07/22 Alibaba, others slow down processors to avoid U.S. sanctions, FT reports 10/24/22 TSMC halts work for Chinese startup Biren Technology, Bloomberg reports 10/19/22 TSMC mulls expanding production capacity in Japan, WSJ reports SHLS Shoals Technologies $22.49 / -0.265 (-1.16%) 06/27/22 German ministry says EU states agree to 40% renewables target, Reuters reports 06/06/22 White House to waive some solar panel tariffs for 24 months, Reuters reports POWW AMMO $3.16 / +0.05 (+1.61%) 09/01/22 Bear Cave's Dorsey sees 'problems' at AMMO NRGV Energy Vault $3.21 / +0.015 (+0.47%) 07/21/22 Culper issues short report on Energy Vault, sees 'gravitational pull to zero' 07/21/22 Culper Research says short Energy Vault, says 'Vaults' are 'doomed' GAN Gan Limited $1.70 / +0.02 (+1.19%) 08/01/22 Massachusetts lawmakers reach last minute deal on sports betting, NBC reports 06/23/22 Fanatics in discussions to enter sports betting business, CNBC reports FXLV F45 Training $3.21 / -0.26 (-7.49%) 08/18/22 F45 Training growth stalls after financing agreement falls through, FT reports TXMD TSM SHLS POWW NRGV NRDY HLLY GAN FXLV DNA DLO BLU AXDX ACLX TXMD TherapeuticsMD $6.51 / -0.44 (-6.33%) 06/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations TSM TSMC $72.81 / -1.02 (-1.38%) 11/09/22 What You Missed On Wall Street On Wednesday 11/09/22 What You Missed On Wall Street This Morning 10/24/22 What You Missed On Wall Street This Morning 10/19/22 What You Missed On Wall Street On Wednesday SHLS Shoals Technologies $22.49 / -0.265 (-1.16%) 09/16/22 What You Missed On Wall Street On Friday 09/16/22 What You Missed On Wall Street This Morning 09/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/15/22 Fly Intel: After-Hours Movers POWW AMMO $3.16 / +0.05 (+1.61%) 10/06/22 What You Missed On Wall Street This Morning 09/01/22 What You Missed On Wall Street On Thursday 09/01/22 What You Missed On Wall Street This Morning 08/16/22 What You Missed On Wall Street On Tuesday NRGV Energy Vault $3.21 / +0.015 (+0.47%) 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning NRDY Nerdy $2.14 / -0.195 (-8.35%) 05/17/22 What You Missed On Wall Street On Tuesday 05/17/22 What You Missed On Wall Street This Morning 05/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/16/22 Fly Intel: After-Hours Movers HLLY Holley $2.98 / -0.215 (-6.74%) 07/29/22 What You Missed On Wall Street On Friday 07/29/22 What You Missed On Wall Street This Morning 06/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations GAN Gan Limited $1.70 / +0.02 (+1.19%) 11/11/22 Bet On It: Propositions to legalize sports betting in California fall short 11/04/22 Bet On It: Could Fertitta's new 6% stake in Wynn turn into more? 10/28/22 Bet On It: Macau stocks pares gains following new COVID infection 10/21/22 Bet On It: NFL under wagers propel sportsbooks to 68% winning percentage FXLV F45 Training $3.21 / -0.26 (-7.49%) 08/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/27/22 Fly Intel: Pre-market Movers DNA Ginkgo Bioworks $2.69 / -0.17 (-5.95%) 10/05/22 Fly Intel: Pre-market Movers 08/16/22 What You Missed On Wall Street This Morning 08/16/22 Fly Intel: Pre-market Movers DLO DLocal $22.62 / -0.18 (-0.79%) 09/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/23/22 What You Missed On Wall Street On Tuesday 08/23/22 What You Missed On Wall Street This Morning 08/23/22 Fly Intel: Pre-market Movers BLU Bellus Health $9.07 / -0.22 (-2.37%) 07/14/22 What You Missed On Wall Street On Thursday 07/14/22 What You Missed On Wall Street This Morning 07/13/22 Fly Intel: After-Hours Movers AXDX Accelerate Diagnostics $1.50 / +0.08 (+5.63%) 08/17/22 Fly Intel: After-Hours Movers ACLX Arcellx $21.54 / -0.88 (-3.93%) 10/27/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/15/22 Global Healthcare Conference 11/17/22 13th Annual Alpha Select Conference 11/14/22 Accelerate Diagnostics - AXDX 11/14/22 ThredUP - TDUP 11/14/22 Energy Vault - NRGV 11/14/22 Holley - HLLY 11/14/22 Gan Limited - GAN 11/14/22 F45 Training - FXLV 11/14/22 Ginkgo Bioworks - DNA 11/14/22 Azenta - AZTA 11/14/22 Nerdy - NRDY 11/14/22 Shoals Technologies - SHLS 11/14/22 AMMO - POWW 11/14/22 Quest Resource - QRHC 11/15/22 dLocal - DLO 12/20/22 Energy Vault Holdings Inc TXMD TSM SHLS POWW NRGV FXLV DNA DLO ACLX TXMD TherapeuticsMD $6.51 / -0.44 (-6.33%) 08/16/22 Largest borrow rate increases among liquid names 08/03/22 TherapeuticsMD options imply 7.6% move in share price post-earnings 06/23/22 Largest borrow rate increases among liquid names 05/31/22 Unusually active option classes on open May 31st TSM TSMC $72.81 / -1.02 (-1.38%) 08/01/22 Unusually active option classes on open August 1st 07/27/22 Unusually active option classes on open July 27th 07/14/22 Unusually active option classes on open July 14th 07/01/22 Taiwan Semi put volume heavy and directionally bearish SHLS Shoals Technologies $22.49 / -0.265 (-1.16%) 11/14/22 Shoals Technologies Group options imply 13.2% move in share price post-earnings 08/15/22 Shoals Technologies Group options imply 12.5% move in share price post-earnings POWW AMMO $3.16 / +0.05 (+1.61%) 08/18/22 Largest borrow rate increases among liquid names 08/15/22 AMMO options imply 11.7% move in share price post-earnings 06/29/22 AMMO options imply 12.4% move in share price post-earnings NRGV Energy Vault $3.21 / +0.015 (+0.47%) 08/30/22 Largest borrow rate increases among liquid names 08/19/22 Largest borrow rate increases among liquid names FXLV F45 Training $3.21 / -0.26 (-7.49%) 09/14/22 Largest borrow rate increases among liquid names DNA Ginkgo Bioworks $2.69 / -0.17 (-5.95%) 11/14/22 Ginkgo Bioworks options imply 12.3% move in share price post-earnings 09/22/22 Largest borrow rate increases among liquid names 09/20/22 Largest borrow rate increases among liquid names 09/12/22 Largest borrow rate increases among liquid names DLO DLocal $22.62 / -0.18 (-0.79%) 11/14/22 DLocal Ltd options imply 19.8% move in share price post-earnings 08/22/22 DLocal Ltd options imply 10.3% move in share price post-earnings 05/17/22 DLocal Ltd options imply 17.5% move in share price post-earnings ACLX Arcellx $21.54 / -0.88 (-3.93%) 07/27/22 new option listings and one option delisting on July 27th
Earnings	Accelerate Diagnostics reports Q3 EPS (18c), consensus (19c) » 16:08 11/14/22 11/14 16:08 11/14/22 16:08 AXDX Accelerate Diagnostics $1.52 / +0.1 (+7.04%) Reports Q3 revenue $3.0M,… Reports Q3 revenue $3.0M, consensus $3.75M. "Our Q3 results were generally in line with my expectations," commented Jack Phillips, CEO. "While I was pleased with the significant progress we made in readying for commercialization with BD and on development of our next generation AST platform, the FDA's challenge of Arc's regulatory status was an unexpected set-back. Despite this news, BD remains committed to our long-term commercial partnership." ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AXDX Accelerate Diagnostics $1.52 / +0.1 (+7.04%) 10/21/22 Accelerate Diagnostics in talks with FDA regarding Accelerate Arc system 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc 05/16/22 Accelerate Diagnostics begins commercialization of Accelerate Arc system AXDX Accelerate Diagnostics $1.52 / +0.1 (+7.04%) 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum AXDX Accelerate Diagnostics $1.52 / +0.1 (+7.04%) 05/16/22 Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c) 19 Aug AXDX Accelerate Diagnostics $1.52 / +0.1 (+7.04%) 08/17/22 Fly Intel: After-Hours Movers 11/14/22 Accelerate Diagnostics - AXDX
Hot Stocks	Accelerate Diagnostics in talks with FDA regarding Accelerate Arc system » 16:06 10/21/22 10/21 16:06 10/21/22 16:06 AXDX Accelerate Diagnostics $1.60 / +0.02 (+1.27%) According to a regulatory… According to a regulatory filing, on October 21, 2022, Accelerate Diagnostics announced it has been in recent discussions with the U.S. Food and Drug Administration regarding its Accelerate Arc system and related BC Kit. Pursuant to such discussions, the FDA has clarified that the company must obtain a 510(k) clearance in order to continue marketing and distributing the Accelerate Arc Products in the United States. The company had been listing the Accelerate Arc Products as a Class I device exempt from 510(k) clearance requirements. Additionally, the FDA requested that the company promptly take certain corrective actions, including, among other things, discontinuing the U.S. marketing and distribution of the Accelerate Arc Products for positive blood culture processing and subsequent identification by mass spectrometry for diagnostic use; removing and/or correcting all U.S. promotional information within the company's control regarding the diagnostic use of the Accelerate Arc Products as Class I devices or as devices intended as positive blood culture processing devices for subsequent identification of microorganisms by mass spectrometry; and revising/removing the company's registration and listing of the Accelerate Arc Products as Class I devices. The company intends to continue to fully cooperate with the FDA, including promptly taking the corrective actions requested by the FDA. On October 21, 2022, the company also submitted a pre-submission package to the FDA, which is intended to obtain FDA feedback regarding the company's contemplated submission of an application for 510(k) clearance for the Accelerate Arc Products. The company cannot, however, give any assurances that FDA will be satisfied with the company's actions taken in response to the matters raised by the FDA in its discussions. The company also cannot give any assurances as to the timing of the FDA's response to the company's pre-submission package or whether the company will be successful in obtaining 510(k) clearance for the Accelerate Arc Products. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AXDX Accelerate Diagnostics $1.60 / +0.02 (+1.27%) 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc 05/16/22 Accelerate Diagnostics begins commercialization of Accelerate Arc system 04/25/22 Accelerate Diagnostics' Arc System kit shows sample accuracy in studies AXDX Accelerate Diagnostics $1.60 / +0.02 (+1.27%) 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum AXDX Accelerate Diagnostics $1.60 / +0.02 (+1.27%) 05/16/22 Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c) 19 Aug AXDX Accelerate Diagnostics $1.60 / +0.02 (+1.27%) 08/17/22 Fly Intel: After-Hours Movers
Syndicate	Accelerate Diagnostics 17.5M share Secondary priced at $2.00 » 06:26 08/19/22 08/19 06:26 08/19/22 06:26 AXDX Accelerate Diagnostics $2.48 / -0.825 (-25.00%) William Blair acted as… William Blair acted as lead book running manager for the offering. ShowHide Related Items >><< Company News Street Research Earnings On The Fly AXDX Accelerate Diagnostics $2.48 / -0.825 (-25.00%) 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc 05/16/22 Accelerate Diagnostics begins commercialization of Accelerate Arc system 04/25/22 Accelerate Diagnostics' Arc System kit shows sample accuracy in studies AXDX Accelerate Diagnostics $2.48 / -0.825 (-25.00%) 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum AXDX Accelerate Diagnostics $2.48 / -0.825 (-25.00%) 05/16/22 Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c) 03/08/22 Accelerate Diagnostics reports Q4 adjusted EPS (23c), consensus (25c) AXDX Accelerate Diagnostics $2.48 / -0.825 (-25.00%) 08/17/22 Fly Intel: After-Hours Movers
On The Fly	Fly Intel: After-Hours Movers » 18:16 08/17/22 08/17 18:16 08/17/22 18:16 WOLF Wolfspeed $85.58 / -3.08 (-3.47%) , CSCO Cisco $46.69 / -0.09 (-0.19%) , KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) , SNPS Synopsys $380.78 / -4.86 (-1.26%) , BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) , DCP DCP Midstream $34.75 / -1.275 (-3.54%) , BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) , AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) , QUIK QuickLogic $7.64 / -0.46 (-5.68%) , BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) , GME GameStop $40.58 / -1.57 (-3.72%) , APRN Blue Apron $5.70 / +0.315 (+5.85%) , FUBO FuboTV $5.36 / -1.005 (-15.80%) , AMC AMC Entertainment $21.36 / -3.45 (-13.91%) … Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WOLF SNPS QUIK KEYS GME FUBO DCP CSCO BLUE BBWI BBBY AXDX APRN AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 08/17/22 Wolfspeed sees 2026 revenue outlook up 30%-40% from prior forecast 08/17/22 Wolfspeed jumps 12% to $95.59 after above-consensus Q4 earnings and guidance 05/09/22 Wolfspeed, Rhombus Energy collaborate for faster EV charging infrastructure 04/25/22 Wolfspeed says Lucid integrates Silicon Carbide solutions into Lucid Air SNPS Synopsys $380.78 / -4.86 (-1.26%) 06/22/22 Synopsys sees WhiteHat Security acquisition neutral to FY22 adjusted EPS 05/27/22 Synopsys initiates $200M ASR with Wells Fargo 05/24/22 Synopsys enters distribution agreement with Arrow Electronics QUIK QuickLogic $7.64 / -0.46 (-5.68%) 06/01/22 QuickLogic awarded new $3.0M eFPGA contract 03/30/22 QuickLogic wins new $1.5M eFPGA contract 03/10/22 QuickLogic wins new eFPGA contract for approximately $1M KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) 08/15/22 Keysight Technologies extends collaboration with Synopsys 08/03/22 Keysight, Nokia collaborate on public 800GE test 07/29/22 The Digital IF Interoperability Consortium announces seven new members 07/13/22 AI-LINK selects Keysight's 5G test tools for performance validation GME GameStop $40.58 / -1.57 (-3.72%) 08/16/22 GameStop trading resumes 08/16/22 GameStop trading halted, volatility trading pause 08/08/22 GameStop trading resumes FUBO FuboTV $5.36 / -1.005 (-15.80%) 08/16/22 FuboTV rises 20.1% 08/11/22 FuboTV adds SportsGrid network 08/08/22 FuboTV rises 14.1% DCP DCP Midstream $34.75 / -1.275 (-3.54%) 08/17/22 Phillips 66 proposing consideration of $34.75 per unit of DCP Midstream 08/17/22 Phillips 66 increases interest in DCP Midstream from 28.26% to 43.31% 08/01/22 DCP Midstream releases annual Sustainability Report 07/19/22 DCP Midstream raises Q2 cash distribution 10% to 43c per unit CSCO Cisco $46.69 / -0.09 (-0.19%) 08/17/22 Cisco expects continued high levels of order backlog 08/17/22 Cisco says cancellations below pre-pandemic levels 08/17/22 Cisco sees Q1 adjusted gross margin 63%-64% 08/17/22 Cisco CEO says full year product orders, backlog at 'record highs' BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 08/17/22 Bluebird Bio confirms Zynteglo wholesale acquisition cost of $2.8M 08/17/22 Bluebird Bio trading resumes 08/17/22 Bluebird Bio to resume trading at 2:30 pm ET 08/17/22 Bluebird Bio confirms FDA approval of Zynteglo BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 08/17/22 Bath & Body Works saw declines in traffic trends in June, first part of July 08/17/22 Bath & Body Works recently cut 130 roles in home office organization 05/19/22 Bath & Body Works sees FY inflation impact $225M-$250M 05/19/22 Bath & Body Works to test new personal care line, including face and hair care BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 08/17/22 Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY 08/17/22 RC Ventures files to sell Bed Bath & Beyond stake 08/17/22 Bed Bath & Beyond trading resumes 08/17/22 Bed Bath & Beyond trading halted, volatility trading pause AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc 05/16/22 Accelerate Diagnostics begins commercialization of Accelerate Arc system 04/25/22 Accelerate Diagnostics' Arc System kit shows sample accuracy in studies APRN Blue Apron $5.70 / +0.315 (+5.85%) 08/17/22 Blue Apron rises 10.6% 08/17/22 Blue Apron rises 22.5% 08/17/22 Blue Apron up 24% at $6.67 in pre-market trading AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/17/22 Cineworld evaluates strategic options amid slow attendance, limited film slate 08/08/22 AMC Entertainment rises 16.9% 08/08/22 AMC Entertainment trading resumes 08/08/22 AMC Entertainment trading halted, volatility trading pause WOLF CSCO KEYS SNPS BLUE DCP BBWI AXDX QUIK BBBY GME APRN FUBO AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 08/15/22 Piper Sandler ON Semiconductor price target raised to $90 from $75 at Piper Sandler 07/14/22 JPMorgan Wolfspeed price target lowered to $80 from $105 at JPMorgan 06/29/22 BofA Wolfspeed price target lowered to $75 from $95 at BofA 06/23/22 Goldman Sachs Wolfspeed upgraded to Buy from Neutral at Goldman Sachs CSCO Cisco $46.69 / -0.09 (-0.19%) 08/15/22 Citi Cisco to trade lower due to valuation multiple compression, says Citi 08/02/22 Citi Arista Networks price target raised to $170 from $160 at Citi 07/15/22 KGI Securities Cisco downgraded to Neutral from Outperform at KGI Securities 07/14/22 JPMorgan Cisco downgraded to Neutral from Overweight at JPMorgan KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) 08/09/22 Deutsche Bank Keysight Technologies price target raised to $190 from $176 at Deutsche Bank 07/14/22 JPMorgan Keysight Technologies price target lowered to $176 from $200 at JPMorgan 06/17/22 UBS Keysight Technologies price target lowered to $177 from $220 at UBS 06/01/22 Goldman Sachs Keysight Technologies price target lowered to $165 from $185 at Goldman Sachs SNPS Synopsys $380.78 / -4.86 (-1.26%) 08/16/22 Wolfe Research Synopsys initiated with an Outperform at Wolfe Research 08/11/22 Wells Fargo Synopsys price target raised to $425 from $375 at Wells Fargo 06/29/22 BofA Synopsys upgraded to Neutral from Underperform at BofA 05/19/22 Needham Synopsys price target raised to $380 from $370 at Needham BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 08/17/22 BTIG Bluebird's approval has positive read for Mustang Bio, says BTIG 08/17/22 Piper Sandler Piper says FDA nod for Bluebird's beta-cel positive for Crispr's exa-cel 08/05/22 Barclays Barclays upgrades Bluebird Bio to Equal Weight, raises price target to $5 08/05/22 Barclays Bluebird Bio upgraded to Equal Weight from Underweight at Barclays DCP DCP Midstream $34.75 / -1.275 (-3.54%) 08/16/22 Barclays DCP Midstream price target raised to $40 from $38 at Barclays 07/20/22 Barclays DCP Midstream price target lowered to $38 from $43 at Barclays 07/12/22 RBC Capital DCP Midstream upgraded to Outperform from Sector Perform at RBC Capital 06/13/22 Raymond James DCP Midstream added to Analyst Current Favorites list at Raymond James BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 08/16/22 B. Riley Bath & Body Works price target raised to $48 from $44 at B. Riley 07/25/22 Barclays Bath & Body Works price target lowered to $33 from $40 at Barclays 07/21/22 Deutsche Bank Bath & Body Works price target lowered to $41 from $61 at Deutsche Bank 07/21/22 B. Riley Bath & Body risk/reward attractive despite guidance cut, says B. Riley AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum QUIK QuickLogic $7.64 / -0.46 (-5.68%) 11/18/21 Roth MKM QuickLogic price target raised to $12 from $8 at Roth Capital BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 08/16/22 Odeon Capital Odeon Capital downgrades Bed Bath & Beyond to Sell with $7.50 price target 08/16/22 Odeon Capital Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital 08/16/22 B. Riley B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell 08/16/22 B. Riley Bed Bath & Beyond downgraded to Sell from Neutral at B. Riley GME GameStop $40.58 / -1.57 (-3.72%) 07/22/22 Wedbush GameStop price target lowered to $7.50 from $30 at Wedbush 05/26/22 Wedbush Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns 03/28/22 B. Riley Bed Bath & Beyond price target raised to $26 from $19 at B. Riley APRN Blue Apron $5.70 / +0.315 (+5.85%) 08/10/22 Lake Street Blue Apron initiated with a Buy at Lake Street 07/20/22 Benchmark Benchmark starts Blue Apron at Buy with turnaround not getting credit 07/20/22 Benchmark Blue Apron initiated with a Buy at Benchmark 05/10/22 Canaccord Blue Apron price target lowered to $10 from $12 at Canaccord FUBO FuboTV $5.36 / -1.005 (-15.80%) 08/17/22 Evercore ISI FuboTV price target raised to $8 from $5 at Evercore ISI 08/17/22 Stephens Stephens sees no major news from FuboTV analyst day to justify 'short squeeze' 08/17/22 Wedbush Wedbush downgrades FuboTV to Neutral, raises price target to $6 08/17/22 Wedbush FuboTV downgraded to Neutral from Outperform at Wedbush AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 07/07/22 Citi AMC Entertainment price target lowered to $5 from $6 at Citi 06/21/22 B. Riley AMC Entertainment price target lowered to $11 from $16 at B. Riley 06/06/22 Citi AMC Entertainment shares remain overvalued, says Citi WOLF SNPS QUIK KEYS GME FUBO DCP CSCO BLUE BBWI BBBY AXDX APRN AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 08/17/22 Wolfspeed sees Q1 EPS (8c) to (2c), consensus (7c) 08/17/22 Wolfspeed reports Q4 EPS (2c), consensus (10c) 05/04/22 Wolfspeed sees Q4 adjusted EPS (13c)-(7c), consensus (12c) 05/04/22 Wolfspeed reports Q3 adjusted EPS (12c), consensus (14c) SNPS Synopsys $380.78 / -4.86 (-1.26%) 08/17/22 Synopsys sees Q4 non-GAAP EPS $1.06-$1.18, consensus $1.73 08/17/22 Synopsys raises FY22 non-GAAP EPS view to $8.80-$8.85 from $7.85-$7.92 08/17/22 Synopsys reports Q3 non-GAAP EPS $2.10 vs $1.81 a year ago QUIK QuickLogic $7.64 / -0.46 (-5.68%) 08/16/22 QuickLogic reports Q2 non-GAAP EPS 0c, consensus (4c) 06/01/22 QuickLogic backs Q2 revenue view $4.5M, consensus $4.47M 05/17/22 QuickLogic reports Q1 adjusted EPS (6c), consensus (7c) KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) 08/17/22 Keysight Technologies sees Q4 adjusted EPS $1.94-$2.00, consensus $1.89 08/17/22 Keysight Technologies reports Q3 adjusted EPS $2.01, consensus $1.78 05/17/22 Keysight Technologies sees FY22 EPS up 14%-15%, consensus $7.01 05/17/22 Keysight Technologies sees Q3 EPS $1.74-$1.80, consensus $1.75 GME GameStop $40.58 / -1.57 (-3.72%) 06/01/22 GameStop reports Q1 EPS ($2.08), consensus ($1.45) 06/01/22 Notable companies reporting after market close 03/17/22 GameStop reports Q4 EPS ($1.94) vs $1.19 last year 03/17/22 Notable companies reporting after market close FUBO FuboTV $5.36 / -1.005 (-15.80%) 08/04/22 FuboTV reports Q2 EPS (45c), consensus (69c) 05/05/22 FuboTV reports Q1 EPS (69c), consensus (65c) 05/05/22 Notable companies reporting after market close 02/23/22 FuboTV reports Q4 EPS (57c), consensus (67c) DCP DCP Midstream $34.75 / -1.275 (-3.54%) 08/02/22 DCP Midstream reports Q2 EPS $1.77, consensus $1.13 05/04/22 DCP Midstream reports Q1 EPS 32c, may not compare to consensus 99c CSCO Cisco $46.69 / -0.09 (-0.19%) 08/17/22 Cisco sees FY23 adjusted EPS $3.49-$3.56, consensus $3.53 08/17/22 Cisco sees Q1 adjusted EPS 82c-84c, consensus 84c 08/17/22 Cisco reports Q4 adjusted EPS 83c, consensus 82c 08/17/22 Notable companies reporting after market close BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 08/04/22 Bluebird Bio reports Q2 EPS ($1.36), consensus ($1.24) 05/09/22 Bluebird Bio reports Q1 EPS ($1.66), consensus ($1.39) 03/04/22 Bluebird Bio reports Q4 EPS ($2.14), consensus ($1.88) BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 08/17/22 Bath & Body Works sees FY revenue down mid to high single digits vs. last year 08/17/22 Bath & Body Works sees Q3 sales down mid to high single digits vs. last year 08/17/22 Bath & Body Works sees FY22 EPS $2.70-$3.00, consensus $2.92 08/17/22 Bath & Body Works sees Q3 EPS 10c-20c, consensus 31c BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 06/29/22 Bed Bath & Beyond reports Q1 adjusted EPS ($2.83), consensus ($1.39) 06/28/22 Notable companies reporting before tomorrow's open 04/13/22 Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 05/16/22 Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c) 03/08/22 Accelerate Diagnostics reports Q4 adjusted EPS (23c), consensus (25c) APRN Blue Apron $5.70 / +0.315 (+5.85%) 08/08/22 Blue Apron cuts FY22 revenue growth view to 7%-13% vs. mid-teens 08/08/22 Blue Apron reports Q2 EPS (68c) vs. (98c) a year ago 05/10/22 Blue Apron targets revenue of $700M-plus in 2024 05/09/22 Blue Apron sees FY revenue growth in mid teens, one est. $532.3M AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/04/22 AMC Entertainment reports Q2 adjusted EPS (20c), consensus (19c) 05/09/22 AMC Entertainment reports Q1 adjusted EPS (52c), consensus (63c) 05/09/22 Notable companies reporting after market close 05/05/22 Hycroft Mining reports Q1 EPS (27c) vs. (16c) last year SNPS GME CSCO BLUE BBBY APRN AMC SNPS Synopsys $380.78 / -4.86 (-1.26%) 04/13/22 Synopsys probed by Commerce Department over China, Bloomberg reports 04/13/22 Synopsys sent subpoena from Commerce Department on China, Blomberg says GME GameStop $40.58 / -1.57 (-3.72%) 08/13/22 Coinbase looking more like a meme stock, Barron's says 07/21/22 Europe game sales rose 13.5% year-over-year in 1H22, Gamesindustry.biz says 07/07/22 GameStop CFO Mike Recupero replaced by Diana Jajeh, Axios says 07/07/22 GameStop CFO out, company making layoffs, Axios says CSCO Cisco $46.69 / -0.09 (-0.19%) 06/23/22 Cisco, Nike planning to fully exit Russia, Reuters reports 06/23/22 Cisco to begin 'orderly wind-down' of Russia business, Reuters reports 06/06/22 CFOs send letter to Treasury Secretary on foreign tax credit rules, WSJ reports BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 08/17/22 Bluebird Bio to charge $2.8M for Zynteglo treatment, Bloomberg says 06/10/22 FDA votes 13-0 in support of Bluebird Bio's Beti-Cel, Bloomberg reports 06/09/22 FDA panel: Bluebird Bio's Eli-Cel benefits outweigh risks, BioPharmaDrive says BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 08/17/22 RC Ventures files to sell entire Bed Bath & Beyond stake, Bloomberg says 08/13/22 Royal Caribbean among companies at risk of liquidity squeeze, Barron's says 08/03/22 Bed Bath & Beyond weighing private loans, Bloomberg reports 08/03/22 Bed Bath & Beyond in talks with private credit providers, Bloomberg says APRN Blue Apron $5.70 / +0.315 (+5.85%) 05/10/22 Blue Apron shares going to $10 unless management 'sociopaths,' Citrons says AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/15/22 Summer movies show audiences, studio chiefs committed to theaters, WSJ reports 07/11/22 U.S. box office sales rising closer to pre-pandemic levels, CNBC reports WOLF SNPS QUIK KEYS GME FUBO CSCO BLUE BBWI BBBY APRN AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 07/22/22 Sell these stocks now, proven algorithm says 07/15/22 Sell these stocks now, proven algorithm says 07/08/22 Sell these stocks now, proven algorithm says 06/24/22 What You Missed On Wall Street On Friday SNPS Synopsys $380.78 / -4.86 (-1.26%) 05/19/22 Fly Intel: Pre-market Movers 05/18/22 Fly Intel: After-Hours Movers 04/13/22 What You Missed On Wall Street On Wednesday QUIK QuickLogic $7.64 / -0.46 (-5.68%) 05/17/22 Fly Intel: After-Hours Movers KEYS Keysight Technologies $169.27 / -1.45 (-0.85%) 03/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations GME GameStop $40.58 / -1.57 (-3.72%) 08/12/22 Short Report: Bed Bath Beyond shorts nudge higher as stock soars 08/09/22 What You Missed This Week in Video Games 08/06/22 Opening Day: Magic Empire opening surge calls to mind AMTD Digital frenzy 08/03/22 Citron says AMTD Digital ‘NOT a meme stock’ despite massive rise in shares FUBO FuboTV $5.36 / -1.005 (-15.80%) 08/17/22 What You Missed On Wall Street This Morning 08/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/12/22 Bet On It: Massachusetts betting bill signed into law ahead of NFL season 05/13/22 Short Report: Upstart shorts take profits as stock craters on guidance cut CSCO Cisco $46.69 / -0.09 (-0.19%) 08/17/22 Here's what Wall Street experts are saying about Cisco ahead of earnings 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street On Thursday BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 08/17/22 What You Missed On Wall Street On Wednesday 08/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/13/22 What You Missed On Wall Street On Monday 06/13/22 Fly Intel: Pre-market Movers BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 07/20/22 What You Missed On Wall Street On Wednesday 07/20/22 What You Missed On Wall Street This Morning 07/20/22 Fly Intel: Pre-market Movers 06/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 08/16/22 Fly Intel: After-Hours Movers 08/16/22 What You Missed On Wall Street On Tuesday 08/16/22 What You Missed On Wall Street This Morning 08/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations APRN Blue Apron $5.70 / +0.315 (+5.85%) 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/04/22 Short Report: GameStop short position reaches 15-month high 06/01/22 Fly Intel: After-Hours Movers AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/15/22 What You Missed On Wall Street This Morning 08/05/22 Fly Intel: Pre-market Movers 08/04/22 Fly Intel: After-Hours Movers 08/17/22 August Virtual Micro Cap Conference 08/17/22 Cisco - CSCO 08/17/22 Keysight Technologies - KEYS 08/17/22 Synopsys - SNPS 08/17/22 Wolfspeed - WOLF 08/18/22 Bath & Body Works - BBWI 09/23/22 Wolfspeed - WOLF 08/19/22 PDUFA Date for betibeglogene autotemcel (beti-cel) 09/16/22 PDUFA Date for Elivaldogene Autotemcel (Eli-cel, Lenti-D) WOLF SNPS GME FUBO CSCO BLUE BBWI BBBY APRN AMC WOLF Wolfspeed $85.58 / -3.08 (-3.47%) 08/17/22 Wolfspeed options imply 9.5% move in share price post-earnings SNPS Synopsys $380.78 / -4.86 (-1.26%) 08/17/22 Synopsys options imply 4.0% move in share price post-earnings 05/19/22 Early notable gainers among liquid option names on May 19th GME GameStop $40.58 / -1.57 (-3.72%) 08/16/22 GameStop call volume above normal and directionally bullish 08/08/22 GameStop call volume above normal and directionally bullish 07/25/22 Notable open interest changes for July 25th 07/22/22 Unusually active option classes on open July 22nd FUBO FuboTV $5.36 / -1.005 (-15.80%) 08/16/22 fuboTV call volume above normal and directionally bullish 08/03/22 Unusually active option classes on open August 3rd 07/15/22 Largest borrow rate increases among liquid names CSCO Cisco $46.69 / -0.09 (-0.19%) 08/17/22 Cisco options imply 4.7% move in share price post-earnings 06/28/22 Cisco put volume heavy and directionally bearish 06/10/22 Cisco put volume heavy and directionally bearish 05/20/22 Notable open interest changes for May 20th BLUE Bluebird Bio $6.78 / +0.195 (+2.96%) 08/12/22 Bluebird Bio call volume above normal and directionally bullish 08/11/22 Bluebird Bio call volume above normal and directionally bullish 08/08/22 Bluebird Bio call volume above normal and directionally bullish 08/05/22 Bluebird Bio call volume above normal and directionally bullish BBWI Bath & Body Works $40.39 / -0.63 (-1.54%) 08/17/22 Bath & Body Works options imply 7.3% move in share price post-earnings 08/16/22 Early notable gainers among liquid option names on August 16th 07/20/22 Bath & Body Works put volume heavy and directionally bearish 07/06/22 Bath & Body Works put volume heavy and directionally bearish BBBY Bed Bath & Beyond $22.98 / +2.24 (+10.80%) 08/17/22 Notable open interest changes for August 17th 08/16/22 Bed Bath & Beyond call volume above normal and directionally bullish 08/16/22 Notable open interest changes for August 16th 08/15/22 Unusually active option classes on open August 15th APRN Blue Apron $5.70 / +0.315 (+5.85%) 08/17/22 Unusually active option classes on open August 17th 08/16/22 Blue Apron call volume above normal and directionally bullish 07/07/22 Largest borrow rate increases among liquid names AMC AMC Entertainment $21.36 / -3.45 (-13.91%) 08/09/22 Notable open interest changes for August 9th 08/08/22 Notable open interest changes for August 8th 08/05/22 Notable open interest changes for August 5th 08/04/22 AMC Entertainment options imply 11.7% move in share price post-earnings
Syndicate	Accelerate Diagnostics announces common stock offering, no amount given » 18:01 08/17/22 08/17 18:01 08/17/22 18:01 AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) Accelerate Diagnostics… Accelerate Diagnostics announced that it has commenced an underwritten public offering of shares of its common stock. William Blair & Company, L.L.C. is acting as lead book-running manager for the offering. Oppenheimer & Co. Inc. is acting as a book-running manager and Craig-Hallum Capital Group LLC is acting as co-manager for the offering. ShowHide Related Items >><< Company News Street Research Earnings AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 07/11/22 Accelerate Diagnostics announces commercialization in Europe of Accelerate Arc 05/16/22 Accelerate Diagnostics begins commercialization of Accelerate Arc system 04/25/22 Accelerate Diagnostics' Arc System kit shows sample accuracy in studies AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 03/09/22 Craig-Hallum Craig-Hallum downgrades Accelerate Diagnostics to Hold, lowers target to $5 03/09/22 Craig-Hallum Accelerate Diagnostics downgraded to Hold from Buy at Craig-Hallum 01/14/22 Craig-Hallum Accelerate Diagnostics price target lowered to $9 from $12 at Craig-Hallum AXDX Accelerate Diagnostics $3.38 / +0.165 (+5.14%) 05/16/22 Accelerate Diagnostics reports Q1 EPS (21c), consensus (30c) 03/08/22 Accelerate Diagnostics reports Q4 adjusted EPS (23c), consensus (25c)

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial